[Biopharmaceutic properties of slow-release codeine phosphate. Drug release from ion exchangers in vitro and in vivo]

Arzneimittelforschung. 1994 Jun;44(6):758-61.
[Article in German]

Abstract

The release of bound codeine (CAS 76-57-3) from a cation exchanger was examined in vitro by the flow-through method and in vivo by measuring the plasma concentrations of codeine after administration of slow-release (Codipront Retard) and standard non-retarded drops. Both sets of results show that codeine release from the ion exchanger is protracted and continuous. Relative to the standard formulation the slow-release codeine drops give a lower maximal plasma concentration (Cmax), a delayed time of maximal concentration (tmax), slower absorption (t0.5) and protracted plasma levels. The in vitro and in vivo results were in good agreement.

MeSH terms

  • Adult
  • Biopharmaceutics
  • Codeine / administration & dosage*
  • Codeine / pharmacokinetics*
  • Delayed-Action Preparations
  • Female
  • Humans
  • Intestinal Absorption
  • Ion Exchange
  • Male
  • Solubility

Substances

  • Delayed-Action Preparations
  • Codeine